Algo version: 0.98b
Upper Street Marketing is listed at the PNK Exchange
Upper Street Marketing [UPPR]
PNK Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is Upper Street Marketing stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Upper Street Marketing 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $0.400, you would have made a loss of $-0.400 per share or -99.98%

We do not have enough data to give you this answer.

Upper Street Marketing has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Upper Street Marketing to be high [0.75 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.